Nombre del producto:3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate

IUPAC Name:7-methoxy-4-oxo-1,4-dihydroquinazolin-6-yl acetate

CAS:179688-53-0
Fórmula molecular:C11H10N2O4
Pureza:95%+
Número de catálogo:CM142178
Peso molecular:234.21

Unidad de embalaje Stock disponible Precio($) Cantidad
CM142178-100g in stock Ǖŭƅ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :179688-53-0
Fórmula molecular:C11H10N2O4
Punto de fusión:-
Código de sonrisas:COC1=C(OC(C)=O)C=C2C(=O)N=CNC2=C1
Densidad:
Número de catálogo:CM142178
Peso molecular:234.21
Punto de ebullición:390°C at 760 mmHg
Nº Mdl:MFCD09833010
Almacenamiento:Store at room temperature.

Category Infos

Quinazolines
Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

Column Infos

SE-9
SE-9 is a novel dual-targeting SOS1/EGFR inhibitor that represents a promising treatment strategy for prostate cancer.
Multitarget medications represent an appealing therapy against the disease with multifactorial abnormalities─cancer. Therefore, simultaneously targeting son of sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR), two aberrantly expressed proteins crucial for the oncogenesis and progression of prostate cancer, may achieve active antitumor effects. 

Related Products